Navigation Links
Ambien and the Other Insomnia Drugs

Ambien is produced and marked by Sanofi-Aventis. It is one of the leading insomnia drug companies. But at present it is in great trouble as its drug is going to go// off-patent this October. There's a range of insomnia drugs on the market, and more are on the way. This is a great relief for some of the people who depend on Ambien for a good night’s sleep.

Good news has been in short supply for the French pharmaceutical company of late. A string of media reports recently highlighted the links between Ambien and sleepwalking, binge eating, and even dangerous nighttime driving.

The side effects though already known and mentioned on the product label are attracting increased attention. It’s just a matter of time before cheaper generic versions of insomnia drugs hit the market. Sanofi-Aventis is hoping to withstand some of the threat. Ambien has the lion's share of the $2 billion prescription insomnia drug market.

Sepracor's Lunesta, available since last April, accounts for about 10%. The drug raked in $329.2 million in its first few months. According to National Sleep Foundation (NSF) it was found that 6 out of l0 people approximately about 126 million people experience at least one symptom of insomnia a few nights a week.

But at present Ian Anderson, an analyst at Cowen & Co, says that only 16% of the patient population is being treated with drug therapy. He also predicts that the market would grow up to 30% this year. Indiplon, created by Pfizer and Neurocrine Biosciences is expected to hit the markets this autumn but their approval by the Food & Drug Administration is pending.

The drug will come in two forms. The short-acting version is meant to help treat jetlag and other short-term sleep needs, such as waking up in the middle of the night. Indiplon's relatively short half-life reduces the hangover-like effect, particularly for people who use the drug in the middle of the night.

But Ambien and Lunesta b oth have longer half-lives, so they are typically not used as middle-of-the-night solutions. But the drug companies have recently asked each other not to begin TV and print advertising of new prescription medicine until physicians have had at least six months to learn more about them.

This is because they feel that ads would generate more immediate interest in a drug. The waiting period is aimed at fostering dialogue between patients and their physicians. It could mean patients will make more informed choices about prescription drugs.


Related medicine news :

1. Aromatherapy: Ambient odors of orange and lavender reduce anxiety
2. Ambien Plus Alcohol Has A Bad Influence on the Drivers
3. Tune Your Brain to Hear Another in a Noisy Ambience
4. FDA Approves First Generic Versions of Ambien for Insomnia
5. Twins Less Prone to Suicide Than Others
6. Sleep Disorders Could Indicate Other Medical Problems
7. Features Of The Brain Affect Asthma And Other Stress Related Disorders
8. Smokers Avoid Dental Care More Than Others
9. Brain Patterns In Amusia May Be Related To Other Disorders
10. Genetic Eye Disorder Can Have Other Implications
11. Some See A Hopeless End, While Others See An Endless Hope
Post Your Comments:

(Date:11/27/2015)... , ... November 27, 2015 , ... ... the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group ... group of Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind ... mental health and wellness consultation, has collaborated with a leading web-based marketplace for ... gap experienced by parents and bring advice from parenting experts within their reach. ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap and ... Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s Santa Rosa ... Sepsis conditions present in similar ways and require time-critical intervention to avoid large area ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity ... have come together on Thanksgiving Day to share the things that they are ... the Serenity Point YouTube channel, patients displayed what they wrote on index cards, ...
(Date:11/26/2015)... VA (PRWEB) , ... November 26, 2015 , ... ... an American Express Travel Representative. As a franchise owner, Somu now offers travelers, ... of cruise, destination wedding packages, private cruise sales, as well as, cabin upgrades ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
(Date:11/26/2015)... STOCKHOLM , November 26, 2015 /PRNewswire/ ... --> Juntendo universitetssjukhus ser potential att ... av magnetresonansbilder (MR-bilder) för patienter med ... tecknat ett forskningsavtal med SyntheticMR AB för ... kliniska forskningsprojekt på sjukhuset. Med SyMRI kan ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
Breaking Medicine Technology: